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Introduction
Xanthomas are lesions characterized by accumu lations of 
lipid-laden macrophages. They are a  common manifestation 
of lipid metabolism disorders, including hyperliproteinemia 
(HLP). HLPs have been classifi ed according to 5 major pheno-
types described in table 1. These phenotypes are based on 
specifi c electrophoretic patterns seen in patients with elevated 
lipoprotein levels. We present a case of a patient presenting 
with gallstones and pancreatitis, initially misdiagnosed as 
gallstone pancreatitis. His skin manifestations in combination 
with an abnormal lab specimen clued us in to the correct 
 diagnosis.
Case
A 28-year-old male presented to the Emergency department 
with abdominal pain. He had a CAT scan which showed 
 extensive peripancreatic edema and cholelithiasis. His 
 amylase and lipase levels were markedly elevated, but his 
LFTs were normal. A diagnosis of gallstone pancreatitis was 
made and the surgical service was consulted. Prior to 
 entering the room, we were cautioned that the patient had 
a, “nasty” rash. On examination, he was found to have the 
 lesions shown on images 1 and 2. Subsequently, we were 
called by the lab stating that the laboratory specimen was 
 lipemic (Image 3), and his triglyceride level was >5000 mg/
dL. This sent us to the textbooks, and we were quick to 
 realize that he had tuberoeruptive xanthomas, most likely 
 related to a form of HLP. He was later diagnosed with 
type III HLP, which was considered the cause of his pan-
creatitis. Both medicine and endocrine were consulted and 
the patient was transferred to the ICU. 
Discussion
The patient was managed in the ICU with IV fl uids, pain 
 control, gemfi brozil/statin, and tight glycemic control for 
 approximately 3 weeks. He recovered from his pancreatitis 
and was discharged home. 
The plan is for an eventual cholecystectomy, but for now, he 
requires tight control of his HLP.
He was diagnosed with Type III HLP, a serious  disorder, with 
lifelong consequences of premature vascular disease and 
 recurrent pancreatitis. Drug treatment (such as HMG-CoA 
 reductase inhibitors/other lipid-lowering drugs) is indicated 















•  Defi cient or abnormal lipoprotein lipase, resulting 
in decreased or absent post heparin lipolytic 
activity
•  Relatively rare
•  Present at birth 
•  Chylomicrons (very low density lipoprotein (VLDL), low 
density lipotein (LDL), high density lipopro plasma 14 
hours or more after last meal
•  Highly elevated serum chylomicrons and triglyceride 
levels, slightly elevated serum cholesterol levels







•  Defi cient cell surface receptors that regulate LDL, 
degradation and cholesterol synthesis, resulting 
in increased levels of plasma LDL over joints and 
pressure points
•  Onset between ages 10 and 30
•  Increased plasma concentrations of LDL
•  Increased serum LDL and cholesterol levels





remnant removal disease, 
xanthomia tuberosum)
•  Unknown underlying defect results in defi cient 
conversion of triglyceride rich VLDL to LDL
•  Uncommon: usually occurs after age 20 but can 
occur earlier in men
•  Abnormal serum beta lipoprotein
•  Elevated cholesterol and tryglyeride






•  Usually occurs secondary to obesity, alcoholism, 
diabetes, or emotional disorders 
•  Relatively common, especially in middle-aged 
men
•  Elevated VLDL levels
•  Abnormal levels of triglycerides in plasma: variable 
increase in serum
•  Normal or slightly elevated serum cholesterol levels
•  Mildly abnormal glucose tolerance
•  Family history





•  Defective triglyceride clearance causes 
pancreatitis usually secondary to another 
disorder, such as obesity or nephrosis
•  Uncommon: onset usually occurs in late 
adolescence or early adulthood
•  Chylomicrons in plasma
•  Elevated plasma VLDV levels
•  Elevated serum cholesterol and triglyceride levels
